Skip to main content
Year archive

Luye Pharma Group Limited — 2019 filings

All 105 regulatory filings released by Luye Pharma Group Limited (2186) in 2019, sourced directly from the official regulator.

105 Filings
2019 Period
2019 filings (105)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT - CDE GRANTED PRIORITY REVIEW STATUS TO NEW DRUG APPLICATION FOR LY03004
Regulatory Filings
2019-12-30 English
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF NDA FOR LY03005 TO THE U.S. FDA
Regulatory Filings
2019-12-26 English
List of Directors and their Roles and Functions
Regulatory Filings
2019-12-24 English
APPOINTMENT OF EXECUTIVE DIRECTORS
Regulatory Filings
2019-12-24 English
DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings
2019-12-19 English
VOLUNTARY ANNOUNCEMENT - ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) COMMENCED PHASE I HEALTHY VOLUNTEER STUDY IN JAPAN
Regulatory Filings
2019-12-12 English
DECISION OF THE LISTING COMMITTEE AND THE SECOND DELISTING STAGE
Regulatory Filings
2019-12-11 English
Interim Report 2019
Regulatory Filings
2019-12-06 English
VOLUNTARY ANNOUNCEMENT - TRIPTORELIN ACETATE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY01007) COMPLETED PHASE I CLINICAL TRIAL IN CHINA
Regulatory Filings
2019-12-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2019
Regulatory Filings
2019-12-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-12-02 English
DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF EQUITY INTEREST IN SHANDONG BOAN
Regulatory Filings
2019-12-01 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019
Regulatory Filings
2019-11-29 English
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTED RISPERIDONE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY03004) NDA FILING
Regulatory Filings
2019-11-26 English
NOTICE OF BOARD MEETING
Regulatory Filings
2019-11-19 English
INSIDE INFORMATION ANNOUNCEMENT
Regulatory Filings
2019-11-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2019
Regulatory Filings
2019-11-05 English
VOLUNTARY ANNOUNCEMENT - LY01008 (BIOSIMILAR TO AVASTIN) COMPLETED PRIMARY ENDPOINT OBSERVATION FOR PHASE III CLINIC TRIAL IN CHINA
Regulatory Filings
2019-11-04 English
VOLUNTARY ANNOUNCEMENT - THE MANUFACTURING FACILITY OF RYKINDO HAS SUCCESSFULLY PASSED USFDA FIRST PAI
Regulatory Filings
2019-11-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-11-01 English
QUARTERLY UPDATE ON STATUS OF RESUMPTION
Regulatory Filings
2019-10-31 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2018/19
Regulatory Filings
2019-10-21 English
VOLUNTARY ANNOUNCEMENT - RELEASE OF SHARE CHARGE OVER SHARES IN THE COMPANY HELD BY CONTROLLING SHAREHOLDER
Regulatory Filings
2019-10-17 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-10-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2019
Regulatory Filings
2019-10-02 English
Interim Report 2019
Regulatory Filings
2019-09-27 English
INSIDE INFORMATION ANNOUNCEMENT - SECOND DELISTING STAGE AND REQUEST FOR REVIEW OF THE STOCK EXCHANGE'S DECISION TO PLACE THE COMPANY IN SECOND DELISTING STAGE
Regulatory Filings
2019-09-19 English
VOLUNTARY ANNOUNCEMENT - GOSERELIN ACETATE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY01005) COMPLETED HUMAN PHARMACOKINETIC STUDY IN THE U.S.
Regulatory Filings
2019-09-19 English
VOLUNTARY ANNOUNCEMENT - LIPUSU AND CMNA HAVE BEEN RECOMMENDED BY 2019 GUIDELINES ON RADIOTHERAPY OF ESOPHAGEAL CANCER
Regulatory Filings
2019-09-16 English
VOLUNTARY ANNOUNCEMENT - XUEZHIKANG TABLETS (LY02404) HAS BEEN APPROVED TO INICIATE CLINICAL TRIALS IN CHINA
Regulatory Filings
2019-09-09 English
ADJUSTMENT TO CONVERSION PRICE OF THE U.S.$300,000,000 1.50 PER CENT. CONVERTIBLE BONDS DUE 2024
Regulatory Filings
2019-09-05 English
CHANGE OF COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT
Regulatory Filings
2019-09-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2019
Regulatory Filings
2019-09-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-09-02 English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Regulatory Filings
2019-08-30 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2019
Regulatory Filings
2019-08-28 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 AUGUST 2019
Regulatory Filings
2019-08-28 English
VOLUNTARY ANNOUNCEMENT - THE GRANT OF PROMOTION RIGHT OF LIPASCOR CAPSULES IN SINGAPORE TO ASTRAZENECA
Regulatory Filings
2019-08-26 English
VOLUNTARY ANNOUNCEMENT - ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) SUBMITTED CLINICAL TRIAL APPLICATION IN JAPAN
Regulatory Filings
2019-08-22 English
NOTICE OF BOARD MEETING
Regulatory Filings
2019-08-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2019
Regulatory Filings
2019-08-06 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-08-01 English
QUARTERLY UPDATE ON STATUS OF RESUMPTION
Regulatory Filings
2019-07-31 English
Environmental, Social and Governance Report 2018
Regulatory Filings
2019-07-26 English
Form of proxy for use by shareholders at the Annual General Meeting to be convened on 28 August 2019 at 3:00 p.m.
Regulatory Filings
2019-07-24 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2019-07-24 English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF DIRECTORS&#x3b; AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2019-07-24 English
Annual Report 2018/19
Regulatory Filings
2019-07-24 English
Next Day Disclosure Return
Regulatory Filings
2019-07-16 English
VOLUNTARY ANNOUNCEMENT - RIVASTIGMINE ONCE A DAY TRANSDERMAL PATCH (13.3MG/24H) RECEIVED MARKETING AUTHORISATION IN GERMANY
Regulatory Filings
2019-07-15 English
NOTICE OF LISTING ON THE STOCK EXCHANGE OF HONG KONG LIMITED U.S.$300,000,000 1.50 PER CENT. CONVERTIBLE BONDS DUE 2024
Regulatory Filings
2019-07-10 English
COMPLETION OF THE ISSUE OF US$300,000,000 1.50 PER CENT. CONVERTIBLE BONDS DUE 2024
Regulatory Filings
2019-07-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2019
Regulatory Filings
2019-07-05 English
SUPPLEMENTAL ANNOUNCEMENT FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2019
Regulatory Filings
2019-07-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-07-02 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2019
Regulatory Filings
2019-06-28 English
PROPOSED ISSUE OF US$300,000,000 1.50 PER CENT. CONVERTIBLE BONDS DUE 2024
Regulatory Filings
2019-06-25 English
DATE OF BOARD MEETING
Regulatory Filings
2019-06-17 English
CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2019-06-14 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 12 JUNE 2019
Regulatory Filings
2019-06-12 English
PROFIT WARNING
Regulatory Filings
2019-06-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2019
Regulatory Filings
2019-06-05 English
VOLUNTARY ANNOUNCEMENT - ACARBOSE CAPSULES PASSED NMPA'S CONSISTENCY EVALUATION
Regulatory Filings
2019-06-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-06-03 English
VOLUNTARY ANNOUNCEMENT - U.S. FDA ACCEPTED RYKINDO NDA FILING
Regulatory Filings
2019-05-29 English
SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2019-05-26 English
UNAUDITED FINANCIAL INFORMATION OF YANTAI LUYE
Regulatory Filings
2019-05-23 English
DISCLOSABLE TRANSACTION ENTERING INTO SECOND SUPPLEMENTAL LETTER OF INTENT AND COMPLETION OF THE DISPOSAL OF A SUBSIDIARY
Regulatory Filings
2019-05-16 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE PRODUCT RIVASTIGMINE MULTI-DAY TRANSDERMAL PATCH COMPLETED PIVOTAL STUDY
Regulatory Filings
2019-05-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2019
Regulatory Filings
2019-05-07 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-05-02 English
QUARTERLY UPDATE ON STATUS OF RESUMPTION
Regulatory Filings
2019-04-30 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 12 JUNE 2019
Regulatory Filings
2019-04-29 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2019-04-29 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2019-04-29 English
Annual Report 2018
Regulatory Filings
2019-04-29 English
VOLUNTARY ANNOUNCEMENT - INCLUSION OF LIPUSU AS FIRST-LINE DRUG IN 2019 CSCO GUIDELINES ON DIAGNOSIS AND TREATMENT OF PRIMARY LUNG CANCER
Regulatory Filings
2019-04-29 English
VOLUNTARY ANNOUNCEMENT - COLLABORATION AND LICENSE AGREEMENT WITH PHARMAMAR TO DEVELOP ONCOLOGY DRUG IN CHINA
Regulatory Filings
2019-04-26 English
List of Directors and their Roles and Functions
Regulatory Filings
2019-04-26 English
RESIGNATION OF EXECUTIVE DIRECTOR, CHANGE IN COMPOSITION OF THE BOARD COMMITTEE AND AUTHORISED REPRESENTATIVE AND APPOINTMENT OF CHIEF FINANCIAL OFFICER
Regulatory Filings
2019-04-26 English
VOLUNTARY ANNOUNCEMENT - REGISTRATION APPLICATION OF PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED RELEASE TABLETS ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Regulatory Filings
2019-04-10 English
VOLUNTARY ANNOUNCEMENT - RECOMBINANT ANTI-RANKL HUMAN MONOCLONAL ANTIBODY INJECTION (LY06006) COMMENCED PHASE III CLINICAL TRIAL IN CHINA
Regulatory Filings
2019-04-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2019
Regulatory Filings
2019-04-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-04-01 English
VOLUNTARY ANNOUNCEMENT - RECOMBINANT HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTIBODY FUSION PROTEIN OPHTHALMIC INJECTION (LY09004) APPROVED FOR CLINICAL TRIAL IN CHINA
Regulatory Filings
2019-03-31 English
VOLUNTARY ANNOUNCEMENT - THE COMPANY SUBMITTED NDA FOR RYKINDO TO THE U.S. FDA
Regulatory Filings
2019-03-28 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2018
Regulatory Filings
2019-03-28 English
NOTICE OF BOARD MEETING
Regulatory Filings
2019-03-14 English
VOLUNTARY ANNOUNCEMENT - ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION (LY03003) COMMENCED PHASE I CLINICAL TRIAL IN JAPAN
Regulatory Filings
2019-03-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2019
Regulatory Filings
2019-03-06 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-03-01 English
RESUMPTION GUIDANCE
Regulatory Filings
2019-02-12 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-02-01 English
CHANGE OF COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT
Regulatory Filings
2019-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2019
Regulatory Filings
2019-02-01 English
EXCHANGE NOTICE - SUSPENSION OF TRADING
Regulatory Filings
2019-02-01 English
DECISION OF LISTING (REVIEW) COMMITTEE AND SUSPENSION OF TRADING
Regulatory Filings
2019-02-01 English
VOLUNTARY ANNOUNCEMENT - THE GRANT OF PROMOTION RIGHT OF XUEZHIKANG CAPSULES IN MAINLAND CHINA TO ASTRAZENECA
Regulatory Filings
2019-01-16 English
Next Day Disclosure Return
Regulatory Filings
2019-01-03 English
Terms of Reference for the Audit Committee (amended on 31 December 2018)
Regulatory Filings
2019-01-03 English
Terms of Reference for the Nomination Committee (amended in 31 December 2018)
Regulatory Filings
2019-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2018
Regulatory Filings
2019-01-03 English
VOLUNTARY ANNOUNCEMENT - RECOMBINANT HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTIBODY FUSION PROTEIN OPHTHALMIC INJECTION BIOSIMILAR (LY09004) CLINICAL TRIAL APPLICATION ACCEPTED IN CHINA
Regulatory Filings
2019-01-03 English
LAPSE OF THE AGREEMENT IN RELATION TO MAJOR TRANSACTION REGARDING ACQUISITION OF 60% EQUITY INTERESTS IN THE TARGET COMPANY
Regulatory Filings
2019-01-02 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2019-01-02 English